Ascentage Pharma's Series B Round

Ascentage Pharma raised a round of funding on December 27, 2016.

Ascentage Pharma is an innovative small-molecule oncology pharma headquartered in Shangha. Ascentage has seven drug programs aimed at six drug targets, three of them clinical-stage.…

Articles about Ascentage Pharma's Series B Round: